Therapeutic Touch Reduces Crying and Improves Sleep in Infants With Colic
Photo by Ben Maffin / Unsplash
Key Takeaway
Consider therapeutic touch as a potential nonpharmacologic intervention for infantile colic, but evidence is preliminary and requires replication.
This randomized controlled trial enrolled 96 infants aged 4 to 8 weeks who met Rome IV criteria for infantile colic. Participants were assigned to receive therapeutic touch based on Watson's Human Care Theory (3 times per week for 1 or 2 weeks) or usual care only. The study was conducted in a hospital outpatient pediatric unit.
The primary outcome was crying time. Infants receiving therapeutic touch showed statistically significant reductions in crying compared with the control group (group × time interaction: F = 222.612; p < .001; η² = 0.827). Secondary outcomes included sleep time and Infant Colic Scale (ICS) scores, both of which also improved significantly (sleep: F = 47.244; p < .001; η² = 0.504; ICS: F = 219.247; p < .001; η² = 0.825). All effect sizes were large. Absolute crying and sleep times were not reported.
Safety and tolerability were not reported, and no adverse events or discontinuations were mentioned. The study did not report funding or conflicts of interest. Limitations include lack of blinding, small sample size, and absence of absolute outcome values, which limits clinical interpretability.
Clinicians should interpret these results cautiously. While therapeutic touch may offer a nonpharmacologic approach for infantile colic, the evidence is preliminary and requires confirmation in larger, blinded trials with standardized outcome measures.
View Original Abstract ↓
OBJECTIVE: We aimed to determine the effect of the different numbers of therapeutic touch sessions, based on Watson's Human Care Theory, on colic symptoms (crying time, sleep time, Infant Colic Scale [ICS]) in infants with infantile colic.
METHODS: This randomized controlled trial included 96 infants aged 4 to 8 weeks who met Rome IV criteria for infantile colic in a hospital outpatient pediatric unit. Infants were randomly assigned into 3 groups: intervention 1 (therapeutic touch for 1 week, n = 32), intervention 2 (therapeutic touch for 2 weeks, n = 32), and control (usual care only, n = 32). In both intervention groups, therapeutic touch was administered in addition to usual care, 3 times per week. Data were collected at baseline and at the 1st, 2nd, 4th, and 8th weeks. The primary outcome was crying time; secondary outcomes were sleep time and ICS Score.
RESULTS: There were statistically significant differences among the groups' crying times ( = 222.612; < .001; = 0.827), sleep times ( = 47.244; < .001; = 0.504), and ICS total scores ( = 219.247; < .001; = 0.825). When infants in intervention groups were compared with the control group infants, the effect size (group × time interaction) was large. Infants receiving therapeutic touch showed reductions in crying and improvements in sleep compared with those receiving usual care. Infants in the 2-week therapeutic touch group demonstrated greater and longer-lasting benefits than those receiving therapeutic touch for 1 week.
CONCLUSIONS: Therapeutic touch based on Watson's Human Care Theory effectively reduced colic symptoms in infants, with greater benefits observed as the number of sessions increased.
TRIAL REGISTRATION: clinicaltrials.gov, NCT05244291.
Standardized formal resuscitation training likely reduces neonatal mortality in low- and middle-income countries compared to no training or basic training
A Simple Training Program Is Saving Newborn Lives in Poor Countries
Related in Pediatrics
Respiratory microbiome composition in children offers new ideas for precision treatment of respiratory diseases and asthma
New ideas for treating children with asthma and respiratory infections
This narrative review examines the respiratory microbiome, metabolites, and colonization in children with respiratory infections, allergic a…
This review offers fresh directions for understanding how the respiratory microbiome affects children with asthma and allergic airway inflam…
Ultrasound may aid pediatric constipation diagnosis in various clinical settings
Ultrasound scans may help doctors diagnose constipation in children
This narrative review examines the role of transabdominal and perianal ultrasonography in pediatric gastroenterology clinics and institution…
Ultrasound scans could become a useful tool for doctors treating constipation in children, offering a new way to see inside without surgery.
Case report describes bilateral simple excision in a 10-year-old child with cervical branchial remnants
Simple surgery removed rare neck growths in a 10-year-old child
This publication is a case report and review of the literature describing a 10-year-old child with bilateral cervical chondrocutaneous branc…
A 10-year-old child with rare neck growths had them removed with simple surgery, showing no safety concerns in this single case report.
High-dose quadrivalent influenza vaccine shows non-inferior immunogenicity in Chinese children aged 6 to 35 months
High-dose flu shots show greater protection for young children in China
This randomized, double-blind study in 3,000 Chinese children aged 6 to 35 months found an investigational high-dose quadrivalent influenza …
A new study in China shows high-dose flu vaccines work as well as or better than standard shots for toddlers, offering stronger protection a…
From Other Specialties
Probiotics, synbiotics, and berberine modestly lower fasting glucose and HbA1c in type 2 diabetes
Probiotics and Berberine Modestly Lower Blood Sugar in Type 2 Diabetes
This meta-analysis of over 2,000 participants found that probiotics, synbiotics, and berberine produced significant but modest reductions in…
Probiotics, synbiotics, and berberine may help lower blood sugar and HbA1c, but the effects are modest.
High-dose ocrelizumab 1200/1800 mg shows no significant difference in disability progression versus 600 mg in MS
High-dose ocrelizumab did not further reduce disability progression in multiple sclerosis patients
This phase 3b randomized controlled trial in 860 and 753 patients with relapsing or primary progressive multiple sclerosis found that high-d…
A large trial found that higher doses of ocrelizumab did not lower the risk of disability progression compared to the standard dose in multi…
Ocrelizumab reduces disability progression risk in primary progressive multiple sclerosis versus placebo
Ocrelizumab reduces disability risk for primary progressive multiple sclerosis patients
This phase 3b trial evaluated intravenous ocrelizumab versus placebo in patients with primary progressive multiple sclerosis. The study foun…
A large trial found ocrelizumab significantly lowers the risk of disability progression in patients with primary progressive multiple sclero…
Prasinezumab showed non-significant delay in motor progression versus placebo in early-stage Parkinson's disease
Early Parkinson's drug trial shows no delay in motor progression
This phase 2b trial evaluated intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable medication. The study f…
A Phase 2b trial of prasinezumab in early Parkinson's disease failed to meet its primary endpoint of delaying motor progression compared to …